查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2000766

中央靜脈導管市場：2026-2032年全球市場預測（按產品類型、管腔數量、材料、尖端形狀、應用和最終用戶分類）

Central Venous Catheters Market by Product Type, Lumen Number, Material, Tip Configuration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，中央靜脈導管市場價值將達到 28 億美元，到 2026 年將成長至 30.7 億美元，到 2032 年將達到 54.9 億美元，年複合成長率為 10.06%。

主要市場統計數據
基準年 2025 28億美元
預計年份：2026年 30.7億美元
預測年份：2032年 54.9億美元
複合年成長率 (%) 10.06%

這份權威報告概述了中央靜脈導管在現代醫療保健流程中的重要性，並揭示了臨床實踐、監管和供應鏈之間的相互依存關係。

中央靜脈導管仍是現代急性及慢性臨床照護的基礎要素，滿足不同病患族群重要的治療、診斷和長期血管通路需求。其應用包括血液透析、長期靜脈輸液、中心靜脈壓監測和靜脈營養，並廣泛應用於醫院、透析中心、門診手術中心、居家照護機構和專科診所等各種場所。隨著臨床需求的不斷變化，醫療設備本身也在不斷改進，以提高安全性、耐用性和操作效率，同時與以門診管理和縮短住院時間為優先的醫療服務模式相適應。

材料創新、分散式醫療服務和監管如何全面重新定義醫療設備的設計、採購和臨床應用？

在創新、醫療環境變化以及支付方和監管機構不斷變化的期望的推動下，中央靜脈導管經歷了快速而多方面的變革。醫療設備設計的進步促成了許多多功能的整合，例如閥尖技術、高壓注射功能、抗菌塗層和改進的管腔形態。這些功能均旨在滿足特定的臨床需求，例如降低感染風險、提高影像相容性和改善血流特性。伴隨這些技術變革，材料科學也取得了長足進步，聚氨酯和矽膠等材料因其在柔軟性、抗血栓性和長期耐久性之間的權衡而備受青睞。

了解 2025 年貿易措施對採購、供應韌性和製造商投資決策的策略和營運影響。

2025年實施的最新關稅措施改變了中央靜脈導管生態系統中相關人員的成本會計和營運策略。對某些原料和成品組件徵收的進口關稅增加了依賴全球供應鏈的製造商和經銷商的採購成本。因此，各組織正在重新評估其供應商組合，協商長期合約以穩定投入成本，並探索近岸外包和區域採購，以降低關稅波動和物流延誤帶來的風險。

細分市場分析揭示了產品類型、臨床應用、最終用戶特徵、管腔結構、材料和尖端配置如何相互交織並影響設備選擇。

為了使臨床需求與器械選擇相匹配，深入了解產品類型細分至關重要。植入式輸液港、非隧道式導管、開口式和帶閥尖端的周邊置入中央靜脈導管，以及隧道式導管（例如 Broviac 導管、Grossong 導管和 Hickman 導管）分別適用於不同的臨床場景和預期使用時長。這些器械分類在置入方法、留置時間、感染風險和維護要求方面存在差異，臨床醫生通常會根據患者的合併症、預期治療時間和手術物流來選擇特定類型。

影響美洲、歐洲、中東和非洲以及亞太地區醫療設備市場創新、監管策略和供應鏈方法的區域趨勢。

區域趨勢對醫療設備的設計重點、監管方式和籌資策略有顯著影響。在美洲，密集的先進醫療設施和透析中心網路促進了多功能醫療設備的快速普及，而支付方結構和集團採購趨勢則影響著價格談判和供應商關係。此外，美洲地區大規模的生產能力也為本地生產創造了機會，有助於緩解跨境貿易壓力（尤其是在關稅體系波動的情況下）。

以創新、臨床證據和供應鏈最佳化為基礎的競爭策略如何重新定義企業定位和成長管道？

中央靜脈導管市場的競爭動態由創新主導產品公司、專業製造商和綜合醫療設備製造商共同構成。市場參與企業在材料科學、導管尖端和管腔結構、感染控制功能以及操作人體工學等許多方面展開競爭。策略性措施通常著重於透過培訓計畫深化與臨床醫生的關係，透過臨床試驗和註冊登記累積證據，並透過與區域分銷商和整合供應鏈合作夥伴建立合作關係來拓展分銷網路。

製造商和醫療保健系統的策略重點是加強供應鏈韌性、提升臨床價值，並加速在各種醫療保健環境中推廣應用。

產業領導者應優先考慮採取多管齊下的方法，在短期業務永續營運與長期創新和臨床價值創造之間取得平衡。加強供應商多元化並建立區域製造地，可以縮短高優先級醫院系統的前置作業時間，同時減輕貿易中斷的影響。此外，透過投資產生臨床證據，證明感染率降低、通暢率提高或手術流程更有效率，可以加強與支付者和採購委員會之間以價值為導向的對話，從而完善價值鏈。

這種高度透明的混合方法結合了對臨床醫生和採購負責人的初步訪談，以及對第二手資料的系統整合，以揭示醫療設備、臨床實踐和當地社區的趨勢。

本研究為上述發現奠定了基礎，它結合了對臨床醫生、採購經理和醫療設備製造商的定性研究，以及對臨床文獻、監管文件和公開技術規範的系統性回顧。研究人員透過訪談收集了關於醫療設備選擇標準、對治療流程的影響以及採購限制等方面的實際觀點。此外，研究人員還整合了醫療設備設計趨勢、材料科學進展和監管指南等輔助分析，以檢驗訪談結果並為其提供背景資訊。

結論強調了創新、醫療保健服務轉型和貿易動態如何共同決定醫療設備製造商和醫療保健系統面臨的策略挑戰。

中央靜脈導管領域正處於轉折點，臨床需求、技術創新和外部政策壓力相互交織，重塑其部署模式和供應商策略。導管尖端形態、材料和管腔結構的技術創新，旨在滿足更安全、更耐用、更通用的血管通路解決方案的特定臨床需求。同時，醫療服務分散化和採購監管的加強，使得人們更加關注醫療總成本和實證差異化。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章中央靜脈導管市場：依產品類型分類

  • 嵌入式連接埠
  • 非隧道導管
  • 周邊置入的中央靜脈導管
    • 開口端
    • 閥門尖端
  • 隧道導管
    • 布羅維亞克
    • 格羅雄
    • 希克曼

第9章中央靜脈導管市場：依管腔數分類

  • 2流明
  • 4流明
  • 1流明
  • 3流明

第10章：中央靜脈導管市場：依材料分類

  • 聚氨酯
  • 矽

第11章中央靜脈導管市場：依導管尖端形狀分類

  • 非電注入
  • 電噴

第12章中央靜脈導管市場：依應用領域分類

  • 血液透析
  • 點滴療法
  • 監測
  • 腸外營養

第13章中央靜脈導管市場：依最終使用者分類

  • 門診手術中心
  • 透析中心
  • 居家照護
  • 醫院
  • 專科診所

第14章中央靜脈導管市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章中央靜脈導管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章中央靜脈導管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國中央靜脈導管市場

第18章：中國中央靜脈導管市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biomerics, LLC
  • Cardinal Health, Inc.
  • CorMedix Inc.
  • Getinge AB
  • ICU Medical, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Smiths Group plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-02026C4C9BC4

The Central Venous Catheters Market was valued at USD 2.80 billion in 2025 and is projected to grow to USD 3.07 billion in 2026, with a CAGR of 10.06%, reaching USD 5.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.80 billion
Estimated Year [2026] USD 3.07 billion
Forecast Year [2032] USD 5.49 billion
CAGR (%) 10.06%

An authoritative overview of central venous catheter relevance in modern care pathways highlighting clinical, regulatory, and supply chain interdependencies

Central venous catheters remain a foundational element of contemporary acute and chronic clinical care, bridging critical therapeutic, diagnostic, and long-term vascular access needs across diverse patient populations. Their use encompasses hemodialysis, prolonged infusion therapy, central venous pressure monitoring, and parenteral nutrition, creating touchpoints across hospitals, dialysis centers, ambulatory surgical environments, home care settings, and specialty clinics. As clinical expectations evolve, devices themselves are adapting to deliver improved safety, durability, and procedural efficiency while aligning with care delivery models that emphasize outpatient management and reduced hospital length of stay.

Technological refinements in materials, tip configurations, and lumen design are reshaping clinician preferences and procedural workflows. Simultaneously, regulatory scrutiny on device safety and infection prevention continues to influence labeling, claims, and post-market surveillance priorities. Supply chain complexity and procurement policies further affect device selection and availability, making operational readiness and supplier relationships key determinants of clinical continuity. This introduction sets the stage for a deeper examination of the forces redefining central venous catheter strategy across clinical, commercial, and policy domains.

How material innovation, decentralized care delivery, and regulatory scrutiny are collectively redefining device design, procurement, and clinical adoption

The landscape for central venous catheters has undergone rapid and multifaceted transformation driven by innovation, shifting care settings, and changing payer and regulatory expectations. Advances in device design now integrate features such as valve-tip technologies, power-injectable compatibility, antimicrobial coatings, and refined lumen geometries, each responding to tangible clinical needs for reduced infection risk, improved imaging compatibility, and enhanced flow characteristics. These engineering changes have been accompanied by improved materials science where polyurethane and silicone are selected based on trade-offs between flexibility, thrombogenicity, and long-term durability.

Concurrently, care delivery has migrated toward decentralized environments. The expansion of ambulatory surgical centers and robust home care programs has increased demand for devices optimized for outpatient insertion, simplified maintenance, and extended dwell time with minimal complication rates. Value-based procurement models and heightened focus on infection prevention have sharpened attention on total cost of care and clinician training as drivers of device adoption. On the regulatory front, authorities are emphasizing evidence of real-world safety and comparative performance, prompting manufacturers to invest in clinical studies and registries. Lastly, manufacturing and supply chain innovations, including additive manufacturing and supplier consolidation, are altering how devices are produced and distributed, creating both opportunities for localized responsiveness and risks of single-source dependency.

Understanding the strategic and operational consequences of 2025 trade measures on procurement, supply resilience, and manufacturer investment choices

Recent tariff measures implemented in 2025 have altered the cost calculus and operational strategies for stakeholders involved in the central venous catheter ecosystem. Import duties on specific raw materials and finished components have increased procurement costs for manufacturers and distributors that rely on global supply networks. As a result, organizations are reassessing supplier portfolios, negotiating longer-term contracts to stabilize input costs, and evaluating nearshoring or regional sourcing to reduce exposure to tariff volatility and logistical delays.

These trade policy shifts have also had downstream implications for hospital procurement and tender processes. Health systems and group purchasing organizations are revisiting total cost analyses that extend beyond unit pricing to include customs, compliance overhead, and inventory carrying costs. For smaller manufacturers and niche suppliers, the tariff environment compounds margin pressure and can constrain investment in product development and clinical studies. In contrast, larger firms with diversified manufacturing footprints may capitalize on scale to absorb short-term cost shocks while strategically relocating production to tariff-favorable jurisdictions.

Operationally, tariffs have accelerated conversations around inventory buffering, dual-sourcing strategies, and supplier qualification processes. Clinicians may experience transient device substitutions as procurement teams balance availability and cost considerations, underscoring the need for comprehensive clinical evaluation when alternate products are introduced. In sum, tariff-driven dynamics are reshaping commercial strategies, supply chain resilience planning, and innovation investment decisions across the central venous catheter landscape.

Segment-level analysis revealing how product types, clinical applications, end-user profiles, lumen architectures, materials, and tip configurations intersect to drive device selection

A granular understanding of product type segmentation is essential for aligning clinical need with device selection. Implantable ports, non-tunneled catheters, peripherally inserted central catheters with their open-ended and valve-tip variants, and tunneled catheters such as Broviac, Groshong, and Hickman models each address distinct clinical scenarios and duration-of-use expectations. These device classes differ in insertion technique, dwell time, infection risk profile, and maintenance requirements, leading clinicians to favor particular types based on patient comorbidity, expected therapy length, and procedural logistics.

Application-based segmentation underscores where demand for specific features is concentrated. Hemodialysis access demands durable lumens and robust flow characteristics, infusion therapy places a premium on dwell reliability and infection prevention, monitoring requires consistent tip positioning and imaging compatibility, and parenteral nutrition prioritizes long-term patency and biocompatible materials. End-user segmentation shapes distribution and training priorities, as ambulatory surgical centers and specialty clinics emphasize fast turnover and streamlined workflows, dialysis centers focus on high-throughput, home care emphasizes device ease-of-maintenance and caregiver training, and hospitals manage the broadest clinical mix with stringent infection control protocols.

Lumen configuration drives clinical versatility, with single, double, triple, and quadruple lumen devices serving different therapeutic combinations and simultaneous delivery needs. Material choice between polyurethane and silicone reflects a balance between flexibility, thrombogenic potential, and long-term resilience. Tip configuration, distinguished by non power injectable versus power injectable designs, affects compatibility with imaging protocols and interventional workflows. Coordinated product development that aligns these segmentation dimensions with clinician training, supply chain readiness, and reimbursement realities will determine which device classes gain traction in specific care pathways.

Regional dynamics shaping device innovation, regulatory strategy, and supply chain approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics materially influence device design priorities, regulatory pathways, and procurement strategies. In the Americas, a dense network of advanced hospitals and dialysis centers supports rapid adoption of feature-rich devices, while payer structures and group purchasing behaviors shape pricing negotiations and supplier relationships. The Americas also host significant manufacturing capacity, enabling opportunities for localized production to mitigate cross-border trade pressures, which is particularly relevant under shifting tariff regimes.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory complexity and varied healthcare funding models lead to differentiated adoption patterns. Western European markets often emphasize robust clinical evidence and post-market surveillance, while parts of the Middle East and Africa prioritize supply reliability and cost-effectiveness. Regional distribution networks and partnerships with local providers become critical to reach fragmented markets and to accommodate diverse clinical practices and infrastructure levels.

Asia-Pacific is characterized by dynamic industrial expansion, growing domestic manufacturing capabilities, and rising demand tied to expanding healthcare access. Diverse regulatory frameworks across countries necessitate tailored market entry strategies and often reward manufacturers that can localize production and clinical support. Across all regions, cross-border logistics, customs policy, and trade measures interplay with regional procurement norms, underscoring the importance of region-specific supply chain strategies and clinician engagement programs when introducing new central venous catheter technologies.

How competitive strategies anchored in innovation, clinical evidence, and supply chain optimisation are redefining company positioning and growth pathways

Competitive dynamics within the central venous catheter space are defined by a mix of innovation-driven product firms, specialized manufacturers, and broad-based medical device companies. Market participants are competing along multiple axes including materials science, tip and lumen configuration, infection-mitigation features, and procedural ergonomics. Strategic behavior often centers on deepening clinician relationships through training programs, evidence generation via clinical studies and registries, and expanding distribution through partnerships with regional distributors and integrated supply channel partners.

Innovation investment is increasingly focused on differentiated value propositions such as power-injectable tip configurations, valve technologies that reduce thrombotic risk, and surface treatments intended to lower infection rates. At the same time, commercial strategies emphasize portfolio breadth to address diverse end-user needs from outpatient infusion to dialysis access. Companies are also optimizing manufacturing footprints and considering vertical integration to control quality and responsiveness, particularly where supply chain resilience can be a competitive advantage. Mergers, acquisitions, and licensing arrangements continue to be tools for accelerating access to new technologies and expanding geographic reach, while regulatory compliance and post-market monitoring remain central to sustaining long-term commercial performance.

Strategic priorities for manufacturers and health systems to fortify supply resilience, amplify clinical value, and accelerate adoption across diverse care settings

Industry leaders should prioritize a multi-pronged approach that balances near-term operational resilience with longer-term innovation and clinical value creation. Strengthening supplier diversification and establishing regional manufacturing options can reduce exposure to trade disruptions while improving lead times for high-priority hospital systems. Complementary to supply chain initiatives, investing in clinical evidence generation that demonstrates reductions in infection rates, improved patency, or procedural efficiencies will enhance value-based conversations with payers and procurement committees.

Manufacturers and distributors should also tailor products and support models to the distinct needs of ambulatory surgical centers, dialysis facilities, home care providers, hospitals, and specialty clinics, recognizing that device requirements and training needs differ markedly across these settings. Embracing digital enablement for clinician education, inventory management, and post-market surveillance can increase product stickiness and provide performance data that informs iterative design improvements. Finally, pricing strategies must be aligned with demonstrated outcomes and total cost of care arguments to maintain competitiveness in tender-driven procurement environments, while partnerships with clinical champions can accelerate adoption of high-value features such as power-injectable compatibility and antimicrobial surfaces.

A transparent mixed-method approach blending primary clinician and procurement interviews with systematic secondary synthesis to map device, clinical, and regional dynamics

The research underpinning these insights combines primary qualitative engagement with clinicians, procurement leaders, and device manufacturers alongside systematic review of clinical literature, regulatory documents, and publicly available technical specifications. Primary interviews were conducted to capture frontline perspectives on device selection criteria, procedural workflow implications, and procurement constraints. Secondary analysis synthesized device design trends, materials science developments, and regulatory guidance to triangulate and contextualize interview findings.

Segmentation analysis was applied to align product attributes with clinical applications, end-user capabilities, lumen configurations, material properties, and tip functionalities. Regional assessments incorporated trade policy analysis, healthcare infrastructure indicators, and observed distribution patterns. To bolster robustness, findings were cross-validated through multiple stakeholder interviews and comparison against clinical practice guidelines. Limitations include variability in local procurement practices and the evolving nature of trade and regulatory landscapes, which necessitate periodic reassessment to maintain relevance. Transparency in methodology and clear documentation of data sources support informed interpretation of the insights presented.

Concluding synthesis emphasising how innovation, care delivery shifts, and trade dynamics jointly determine strategic imperatives for device makers and health systems

The central venous catheter domain is at an inflection point where clinical demand, technological innovation, and external policy pressures converge to reshape adoption patterns and supplier strategies. Device innovation in tip configuration, materials, and lumen architecture is responding to concrete clinical needs for safer, more durable, and more versatile vascular access solutions. At the same time, decentralized care delivery models and heightened procurement scrutiny are refocusing attention on total cost of care and evidence-based differentiation.

Trade measures enacted in 2025 have amplified the importance of supply chain resiliency and regional manufacturing strategies, compelling stakeholders to balance cost optimization with uninterrupted clinical availability. Segmentation insights reveal that product choices are tightly coupled to application-specific performance requirements and end-user operational realities, suggesting that companies that can align design, evidence, and support with clinical workflows will secure stronger adoption. Overall, informed strategic action that integrates supply chain planning, rigorous clinical validation, and targeted commercialization will be decisive in capturing long-term value in this evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Central Venous Catheters Market, by Product Type

  • 8.1. Implantable Port
  • 8.2. Non Tunneled Catheter
  • 8.3. Peripherally Inserted Central Catheter
    • 8.3.1. Open Ended
    • 8.3.2. Valve Tip
  • 8.4. Tunneled Catheter
    • 8.4.1. Broviac
    • 8.4.2. Groshong
    • 8.4.3. Hickman

9. Central Venous Catheters Market, by Lumen Number

  • 9.1. Double Lumen
  • 9.2. Quadruple Lumen
  • 9.3. Single Lumen
  • 9.4. Triple Lumen

10. Central Venous Catheters Market, by Material

  • 10.1. Polyurethane
  • 10.2. Silicone

11. Central Venous Catheters Market, by Tip Configuration

  • 11.1. Non Power Injectable
  • 11.2. Power Injectable

12. Central Venous Catheters Market, by Application

  • 12.1. Hemodialysis
  • 12.2. Infusion Therapy
  • 12.3. Monitoring
  • 12.4. Parenteral Nutrition

13. Central Venous Catheters Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Dialysis Centers
  • 13.3. Home Care
  • 13.4. Hospitals
  • 13.5. Specialty Clinics

14. Central Venous Catheters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Central Venous Catheters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Central Venous Catheters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Central Venous Catheters Market

18. China Central Venous Catheters Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AngioDynamics, Inc.
  • 19.6. Asahi Kasei Corporation
  • 19.7. B. Braun Melsungen AG
  • 19.8. Becton, Dickinson and Company
  • 19.9. Biomerics, LLC
  • 19.10. Cardinal Health, Inc.
  • 19.11. CorMedix Inc.
  • 19.12. Getinge AB
  • 19.13. ICU Medical, Inc.
  • 19.14. Medtronic plc
  • 19.15. Merit Medical Systems, Inc.
  • 19.16. Smiths Group plc
  • 19.17. Teleflex Incorporated
  • 19.18. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CENTRAL VENOUS CATHETERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CENTRAL VENOUS CATHETERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY IMPLANTABLE PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON TUNNELED CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY OPEN ENDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY VALVE TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY BROVIAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROSHONG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HICKMAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY QUADRUPLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY NON POWER INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY POWER INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 174. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 175. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. GCC CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 203. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. G7 CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TUNNELED CATHETER, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY LUMEN NUMBER, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA CENTRAL VENOUS CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)